{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:53:53Z","timestamp":1787014433308,"version":"build-2736575974"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T00:00:00Z","timestamp":1142294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T00:00:00Z","timestamp":1142294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1111\/j.1365-2133.2006.07197.x","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T05:41:06Z","timestamp":1142314866000},"page":"999-1000","source":"Crossref","is-referenced-by-count":13,"title":["Venlafaxine-associated psoriasiform palmoplantar keratoderma and subungual hyperkeratosis"],"prefix":"10.1093","volume":"154","author":[{"given":"S.","family":"Dalle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Becuwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Balme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,3,14]]},"reference":[{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1001\/jama.283.23.3082","article-title":"Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial","volume":"283","author":"Gelenberg","year":"2000","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1176\/appi.ajp.158.7.1159-a","article-title":"Venlafaxine-induced hair loss","volume":"158","author":"Pitchot","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4088\/JCP.v65n1020d","article-title":"A possible case of venlafaxine-induced Stevens-Johnson syndrome","volume":"65","author":"Weiss","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3904\/kjim.2004.19.2.132","article-title":"Nail changes during docetaxel containing combination chemotherapy","volume":"19","author":"Woo","year":"2004","journal-title":"Korean J Intern Med"},{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB5|cit5","first-page":"476","article-title":"Clofazimine induced nail changes","volume":"61","author":"Dixit","year":"1989","journal-title":"Indian J Lepr"},{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB6|cit6","first-page":"2061","article-title":"Verapamil as a cause of palmar hyperkeratosis","volume":"103","author":"Major","year":"1983","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archderm.131.3.364","article-title":"Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur","volume":"131","author":"Jucgla","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archderm.1987.01660300073015","article-title":"Glucan-induced keratoderma in acquired immunodeficiency syndrome","volume":"123","author":"Duvic","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB9|cit9","first-page":"149","article-title":"Keratodermia: side effects of lithium","volume":"11","author":"Labelle","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/j.1365-2133.2006.07197.x-BIB10|cit10","first-page":"637","article-title":"Drug eruptions caused by lithium salts","volume":"135","author":"Lambert","year":"1984","journal-title":"Ann Med Interne (Paris)"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07197.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07197.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2006.07197.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:16:31Z","timestamp":1676366191000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/154\/5\/999\/6637036"}},"subtitle":["Correspondence"],"short-title":[],"issued":{"date-parts":[[2006,3,14]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07197.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3,14]]}}}